"CORRELATION BETWEEN DRUG-RELATED PROBLEMS AND THE TREATMENT COST FOR GERIATRIC ISCHEMIC STROKE PATIENTS" by dhanang prawira nugraha and martanty aditya
  •  
  •  
 

Abstract

Ischemic stroke was one of the diseases that frequently occurred in geriatric patients, while hemorrhagic stroke had a higher prevalence. Geriatric patients who experienced a stroke were not exempt from drug-related problems (DRP) due to the complexity of treatment and comorbid factors they encountered. This study aimed to determine the correlation between DRP and the cost of care for ischemic stroke patients, particularly in the geriatric population. The study design was cross-sectional, with data collected retrospectively, and the sample comprised 53 geriatric stroke patients who met the inclusion and exclusion criteria. DRP was assessed using the PCNE 6.2 criteria, and the cost data included expenses for medications, medical devices, laboratory tests, visit fees, accommodation, diagnostic electromedical procedures, radiology, nutrition, and insurance. The independent variable in this study was DRP, while the dependent variable was the cost of care. The analysis used in this study was Spearman's correlation and was presented with a correlation coefficient (R). The results showed a significant correlation between DRP and care costs (p-value < 0.05), with a correlation coefficient 0.501. The study concluded with the assertion that an increase in DRP is associated with elevated costs of care for geriatric ischemic stroke patients.

References

Ahmad, A. et al. (2014) ‘Identification of drug-related problems of elderly patients discharged from hospital.’, Patient preference and adherence, 8, pp. 155–65. Available at: https://doi.org/10.2147/PPA.S48357.

Al-Taani, G.M. et al. (2024) ‘Costs saved and avoided from pharmacist interventions to address drug-related problems identified from outpatient clinics in Jordan’, PLoS ONE, 19(6.0), pp. 1–13. Available at: https://doi.org/10.1371/journal.pone.0302287.

Buisman, L.R. et al. (2015) ‘Hospital costs of ischemic stroke and TIA in the Netherlands’, Neurology, 84(22), pp. 2208–2215.

Andayani, T.M. and Satibi, S. (2016) ‘Chapter 3 - Pharmacy Practice in Indonesia’, in A.I. Fathelrahman, M.I.M. Ibrahim, and A.I.B.T.-P.P. in D.C. Wertheimer (eds). Boston: Academic Press, pp. 41–56. Available at: https://doi.org/https://doi.org/10.1016/B978-0-12-801714-2.00003-4.

Andriani, R., Karsana, A.R. and Satyaweni, I. (2019) ‘Pengaruh Pemberian Asuhan Kefarmasian Terhadap Kejadian Permasalahan Terkait Obat Pasien Geriatri Rawat Inap di RSUP Sanglah Denpasar Effect of Pharmaceutical Care in the Management of Drug Related Problems in Hospitalized Geriatric Patients at Sanglah Ho’, PHARMACEUTICAL JOURNAL OF INDONESIA, 4(2), pp. 79–83.

Chen, Q. et al. (2020) ‘Characteristics of drug-related problems among hospitalized ischemic stroke patients in China’, International Journal of Clinical Pharmacy, 42, pp. 1237–1241.

Cipolle, R.J., Strand, L.M. and Morley, P.C. (2012) Pharmaceutical care practice: The patient-centered approach to medication management services, 3rd edition. New York: McGraw-Hill.

Firmansyah, F., Andayani, T.M. and Pinzon, R.T. (2016) ‘Analisis biaya penyakit stroke iskemik’, Jurnal Manajemen Dan Pelayanan Farmasi (Journal of Management and Pharmacy Practice), 6(1), pp. 27–34.

Holmegard, H.N. et al. (2016) ‘Sex Hormones and Ischemic Stroke: A Prospective Cohort Study and Meta-Analyses’, The Journal of Clinical Endocrinology & Metabolism, 101(1), pp. 69–78. Available at: https://doi.org/10.1210/jc.2015-2687.

Huang, S. et al. (2022) ‘Research progress on the role of hormones in ischemic stroke’, Frontiers in immunology, 13, p. 1062977.

Kementrian kesehatan RI (2018) ‘Hasil utama riskesdas 2018’, p. 61.

Laily, S.R. (2017) ‘Hubungan karakteristik penderita dan hipertensi dengan kejadian stroke iskemik’, Jurnal berkala epidemiologi, 5(1), pp. 48–59.

Liu, H. et al. (2022) ‘Length of Stay, Hospital Costs and Mortality Associated With Comorbidity According to the Charlson Comorbidity Index in Immobile Patients After Ischemic Stroke in China: A National Study’, International Journal of Health Policy and Management, 11(9), pp. 1780–1787. Available at: https://doi.org/10.34172/IJHPM.2021.79.

Madhan, R. and Vineetha, M. (2016) ‘Evaluation Of Clinical And Economic Impact Of Drug Related Problems In Elderly Patients At Tertiary Care Hospital’, Value in Health, 19(7), p. A483.

Maydinar, D.D., Effendi, S. and Sonalia, E. (2017) ‘Hipertensi, Usia, Jenis Kelamin Dan Kejadian Stroke di Ruang Rawat Inap Stroke RSUD dr. M. Yunus Bengkulu’, Jurnal Sains Kesehatan Vol, 24(2).

Nadhifah, T.A. and Sjarqiah, U. (2022) ‘Gambaran Pasien Stroke Pada Lansia di Rumah Sakit Islam Jakarta Sukapura Tahun 2019’, Muhammadiyah Journal of Geriatric, 3(1), p. 23. Available at: https://doi.org/10.24853/mujg.3.1.23-30.

Pharmaceutical Care Network Europe (2010) ‘Classification of drug-related problems V6.2’, 127(23), pp. 3073–6. Available at: https://www.pcne.org/upload/files/11_PCNE_classification_V6-2.pdf.

Rajakumar, S. et al. (2024) ‘Evaluation of drug-related problems and cost-saving of pharmacist-led intervention among hospitalized elderly patients’, Journal of Pharmaceutical Health Services Research, 15(2). Available at: https://doi.org/10.1093/jphsr/rmae010.

Republik Indonesia (1998) Undang-undang Republik Indonesia Nomor 13 tahun 1998 tentang Kesejahteraan Lanjut Usia. Indonesia. Available at: https://doi.org/10.1017/CBO9781107415324.004.

Ryan, M. and Nestor, M. (2020) ‘Stroke’, in J.T. Dipiro et al. (eds) Pharmacotherapy: A Pathophysiologic Approach, Eleventh Edition 11th Edition. 11th edn. McGraw-Hill.

Semcharoen, K. et al. (2019) ‘Characteristic of drug ‑ related problems and pharmacists ’ interventions in a stroke unit in Thailand’, International Journal of Clinical Pharmacy [Preprint]. Available at: https://doi.org/10.1007/s11096-019-00832-4.

Silva, C. et al. (2015) ‘Drug-related problems in institutionalized, polymedicated elderly patients: opportunities for pharmacist intervention’, International Journal of Clinical Pharmacy, 37(2), pp. 327–334. Available at: https://doi.org/10.1007/s11096-014-0063-2.

Somers, A. et al. (2010) ‘Contribution of Drug Related Problems To Hospital Admission’, Journal of Nutrition, Health & Aging, The, 14(17), pp. 477–482.

Strilciuc, S. et al. (2021) ‘The economic burden of stroke: a systematic review of cost of illness studies’, Journal of Medicine and Life, 14(5), pp. 606–619. Available at: https://doi.org/10.25122/jml-2021-0361.

Thammisetty, D.P., Ranganayakulu, D. and Nayakanti, D. (2021) ‘Drug-related problems and its prescribing indicators in stroke patients: a prospective observational study’, Asian J Pharm Clin Res, 14(3), pp. 141–144.

Tian, L. et al. (2023) ‘Drug-related problems among community-dwelling elderly with ischemic stroke in China’, Advances in Clinical and Experimental Medicine, 32(4), pp. 423–432.

Watanabe, J.H., McInnis, T. and Hirsch, J.D. (2018) ‘Cost of Prescription Drug–Related Morbidity and Mortality’, Annals of Pharmacotherapy, 52(9), pp. 829–837. Available at: https://doi.org/10.1177/1060028018765159.

Yuniar, Y. et al. (2023) ‘Medicines Cost Analysis for Inpatient Ischemic Stroke in Indonesia’, Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022), 1, pp. 611–620. Available at: https://doi.org/10.2991/978-94-6463-112-8_56.

Zaqiah, F. et al. (2024) ‘Analisis Cost of Illness Pada Pengobatan Pasien Stroke Iskemik Peserta JKN di RS X ” Surakarta Tahun 2023’, Jurnal Mandala Pharmacon Indonesia\, 10(2), pp. 338–345.

Zeller, T. et al. (2018) ‘Low testosterone levels are predictive for incident atrial fibrillation and ischaemic stroke in men, but protective in women–results from the FINRISK study’, European journal of preventive cardiology, 25(11), pp. 1133–1139.

Zhu, D. et al. (2022) ‘Medical Service Utilization and Direct Medical Cost of Stroke in Urban China’, International Journal of Health Policy and Management, 11(3), pp. 277–286. Available at: https://doi.org/10.34172/ijhpm.2020.111.

Bahasa Abstract

Salah satu penyakit yang sering terjadi pada pasien geriatri adalah stroke iskemik. Stroke hemoragik memiliki prevalensi lebih banyak dibandingkan dengan stroke hemoragik. Pasien geriatri yang mengalami stroke tidak luput dari drug related problems (DRP) karena kompleksnya pengobatan dan faktor komorbiditas yang dialami. Penelitian ini bertujuan untuk mengetahui korelasi antara DRP dengan biaya perawatan pasien stroke iskemik khususnya pada pasien geriatri. Metode dari penelitian ini adalah cross-sectional dengan data yang dikumpulkan secara retrospektif, sampel pada penelitian ini adalah pasien geriatri yang mengalami stroke yang memenuhi kriteria inklusi dan eksklusi sebanyak 53 pasien. DRP pada penelitian ini menggunakan kriteria PCNE 6.2 dan data biaya pada penelitian ini meliputi biaya obat, alat kesehatan, laboratorium, visite fee, akomodasi, elelktromedik diagnostik, radiologi, gizi serta asuransi. Variabel bebas pada penelitian ini adalah DRP sedangkan variabel terikatnya adalah biaya perawatan. Analisis yang digunakan pada penelitian ini adalah Spearman dan dipresentasikan dengan nilai koefisien korelasi (R). Hasilnya terdapat korelasi yang signifikan antara DRP dengan biaya perawatan (p-value < 0,05) dan koefisien korelasinya sebesar 0,501 sehingga dapat disimpulkna bahwa semakin besar DRP maka akan semakin besar juga biaya perawatan pasien stroke iskemik geriatri.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.